Participants were randomly assigned in a 2:1:1:1:1:2:2 ratio to receive subcutaneous retatrutide (1 mg, 4 mg [initial dose, 2 mg], 4 mg [initial dose, 4 mg], 8 mg [initial dose, 2 mg], 8 mg [initial dose, 4 mg], or 12 mg [initial dose, 2 mg]) or placebo once weekly for 48 weeks
GLP-1s look promising for substance use disorders, but we dont yet know how effective they might be
Retatrutide adds substantial weight loss and additional glycemic control
This section will help you identify the signs of severe allergic reactions, understand the symptoms that need urgent care, and the importance of having an emergency plan
For individuals struggling with obesity-related conditions such as Type 2 diabetes, hypertension, and sleep apnea, bariatric surgery has shown remarkable improvements in both physical health and emotional well-being
Patients scheduled for procedures requiring anesthesiawhether general, regional, or monitored sedationshould proactively inform their surgical team about tirzepatide use
